People
After Joichi “Joi” Ito resigned from his post as director of the MIT Media Lab following revelations of his connections with disgraced financier Jeffrey Epstein, Boston-based Puretech Health announced this morning that he has also resigned from his position as chairman of that company’s board of directors.
Nearly one year after it was launched by Pfizer and Bain Capital, Cerevel Therapeutics has tapped industry veteran Tony Coles as its chief executive officer.
Gelest, Inc., a leading innovator in materials science, announced that its Founder, President and Chief Technology Officer Dr. Barry Arkles is the recipient of the American Chemical Society 2020 Frederic Stanley Kipping Award in Silicon Chemistry.
Crescendo Biologics Ltd announces that Stewart Kay has been appointed as the Company’s Chief Business Officer.
Former Ogilvy and WPP executive, David Mayo has joined Verita Healthcare Group, a global provider of preventative, personalised healthcare and wellness clinics, as Group Sales and Marketing Director.
Avillion LLP announces the appointment of Dr Anders Gersel Pedersen as a Non-Executive Director of Bond 2 Development 2 GP, the General Partner of Bond Avillion 2, the Avillion entity that enters into the co-development agreements with pharma partners.
Global Blood Therapeutics, Inc. announced that on September 1, 2019, the compensation committee of GBT’s board of directors granted Eric Fink and 8 new employees options to purchase an aggregate of 47,600 shares of the company’s common stock with a per share exercise price of $45.98 and restricted stock units for an aggregate of 54,425 shares of the company’s common stock.
Auris Medical Holding Ltd. announced the appointment of Elmar Schärli, CPA, as new Chief Financial Officer, effective November 1, 2019.
Biopharma companies strengthen the C-suite and board of directors with these appointments.
Biofidelity Ltd announces it has secured £0.75 million seed financing, following its formation earlier this year.
PRESS RELEASES